BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21370049)

  • 41. Genetic and in vitro assays of DNA deamination.
    Coker HA; Morgan HD; Petersen-Mahrt SK
    Methods Enzymol; 2006; 408():156-70. PubMed ID: 16793368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-redundancy of cytidine deaminases in class switch recombination.
    Fugmann SD; Rush JS; Schatz DG
    Eur J Immunol; 2004 Mar; 34(3):844-849. PubMed ID: 14991614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.
    Swanton C; McGranahan N; Starrett GJ; Harris RS
    Cancer Discov; 2015 Jul; 5(7):704-12. PubMed ID: 26091828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis.
    Taylor BJ; Nik-Zainal S; Wu YL; Stebbings LA; Raine K; Campbell PJ; Rada C; Stratton MR; Neuberger MS
    Elife; 2013 Apr; 2():e00534. PubMed ID: 23599896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants of sequence-specificity within human AID and APOBEC3G.
    Carpenter MA; Rajagurubandara E; Wijesinghe P; Bhagwat AS
    DNA Repair (Amst); 2010 May; 9(5):579-87. PubMed ID: 20338830
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification.
    Petersen-Mahrt SK; Harris RS; Neuberger MS
    Nature; 2002 Jul; 418(6893):99-103. PubMed ID: 12097915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetic reprogramming: is deamination key to active DNA demethylation?
    Teperek-Tkacz M; Pasque V; Gentsch G; Ferguson-Smith AC
    Reproduction; 2011 Nov; 142(5):621-32. PubMed ID: 21911441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural resistance to HIV infection: The Vif-APOBEC interaction.
    Malim MH
    C R Biol; 2006 Nov; 329(11):871-5. PubMed ID: 17067930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disruption of Transcriptional Coactivator Sub1 Leads to Genome-Wide Re-distribution of Clustered Mutations Induced by APOBEC in Active Yeast Genes.
    Lada AG; Kliver SF; Dhar A; Polev DE; Masharsky AE; Rogozin IB; Pavlov YI
    PLoS Genet; 2015 May; 11(5):e1005217. PubMed ID: 25941824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The nuclear DNA deaminase AID functions distributively whereas cytoplasmic APOBEC3G has a processive mode of action.
    Coker HA; Petersen-Mahrt SK
    DNA Repair (Amst); 2007 Feb; 6(2):235-43. PubMed ID: 17161027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Secreted novel AID/APOBEC-like deaminase 1 (SNAD1) - a new important player in fish immunology.
    Majewska AM; Dietrich MA; Budzko L; Adamek M; Figlerowicz M; Ciereszko A
    Front Immunol; 2024; 15():1340273. PubMed ID: 38601149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
    Lindley RA; Hall NE
    Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AID upmutants isolated using a high-throughput screen highlight the immunity/cancer balance limiting DNA deaminase activity.
    Wang M; Yang Z; Rada C; Neuberger MS
    Nat Struct Mol Biol; 2009 Jul; 16(7):769-76. PubMed ID: 19543289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
    Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA-cytosine deaminases: from antibody maturation to antiviral defense.
    Bhagwat AS
    DNA Repair (Amst); 2004 Jan; 3(1):85-9. PubMed ID: 14697763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1.
    Xie K; Sowden MP; Dance GS; Torelli AT; Smith HC; Wedekind JE
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8114-9. PubMed ID: 15148397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New Insights Into the Lineage-Specific Expansion and Functional Diversification of Lamprey AID/APOBEC Family.
    Chen Y; Luo L; Deng L; Tian X; Chen S; Xu A; Yuan S
    Front Immunol; 2022; 13():822616. PubMed ID: 35359986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Replication protein A (RPA) hampers the processive action of APOBEC3G cytosine deaminase on single-stranded DNA.
    Lada AG; Waisertreiger IS; Grabow CE; Prakash A; Borgstahl GE; Rogozin IB; Pavlov YI
    PLoS One; 2011; 6(9):e24848. PubMed ID: 21935481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
    Roberts SA; Lawrence MS; Klimczak LJ; Grimm SA; Fargo D; Stojanov P; Kiezun A; Kryukov GV; Carter SL; Saksena G; Harris S; Shah RR; Resnick MA; Getz G; Gordenin DA
    Nat Genet; 2013 Sep; 45(9):970-6. PubMed ID: 23852170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AID and APOBEC deaminases: balancing DNA damage in epigenetics and immunity.
    Franchini DM; Petersen-Mahrt SK
    Epigenomics; 2014; 6(4):427-43. PubMed ID: 25333851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.